116 related articles for article (PubMed ID: 2557367)
1. Influence of standard and novel LTB4 analogs on human neutrophil chemotaxis measured by the multiwell cap assay.
Psychoyos S; Uziel-Fusi S; Bhagwat S; Morrissey MM
J Immunol Methods; 1989 Nov; 124(2):189-96. PubMed ID: 2557367
[TBL] [Abstract][Full Text] [Related]
2. Comparison of LTB4- and C5a-stimulated chemotaxis of isolated human neutrophils: difference revealed by cell migration in thick filters using the multiwell cap procedure.
Psychoyos S; Uziel-Fusi S
Agents Actions; 1989 Jun; 27(3-4):380-4. PubMed ID: 2552766
[TBL] [Abstract][Full Text] [Related]
3. Thick filter neutrophil chemotaxis performed in the absence of albumin.
Psychoyos S; Uziel-Fusi S; Morrissey MM; Ganu V; Smith CW
J Immunol Methods; 1991 Mar; 137(1):37-46. PubMed ID: 1849155
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
5. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.
Pettipher ER; Salter ED; Breslow R; Raycroft L; Showell HJ
Br J Pharmacol; 1993 Sep; 110(1):423-7. PubMed ID: 8220903
[TBL] [Abstract][Full Text] [Related]
7. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
8. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
[TBL] [Abstract][Full Text] [Related]
9. Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors.
Bomalaski JS; Mong S
Prostaglandins; 1987 Jun; 33(6):855-67. PubMed ID: 2823316
[TBL] [Abstract][Full Text] [Related]
10. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro.
Czarnetzki BM; Rosenbach T
Prostaglandins; 1986 May; 31(5):851-8. PubMed ID: 3014612
[TBL] [Abstract][Full Text] [Related]
11. Effect of structural modification at carbon atom 1 of leukotriene B4 on the chemotactic and metabolic response of human neutrophils.
Clancy RM; Dahinden CA; Hugli TE
Anal Biochem; 1987 Mar; 161(2):550-8. PubMed ID: 3034102
[TBL] [Abstract][Full Text] [Related]
12. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.
Kankaanranta H; Moilanen E; Vapaatalo H
Inflammation; 1991 Apr; 15(2):137-43. PubMed ID: 1649132
[TBL] [Abstract][Full Text] [Related]
13. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
Patrick RA; Peters PA; Issekutz AC
Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil chemotaxis to leukotriene B4 in vitro is decreased for the human neonate.
Dos Santos C; Davidson D
Pediatr Res; 1993 Mar; 33(3):242-6. PubMed ID: 8384710
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for chemotactic activity of leukotriene B4 (LTB4).
Hoffstein ST; Manzi RM; Razgaitis KA; Bender PE; Gleason J
Prostaglandins; 1986 Feb; 31(2):205-15. PubMed ID: 3008215
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
20. Comparison of leukotriene B4-induced neutrophil migration through different cellular barriers.
Casale TB; Abbas MK
Am J Physiol; 1990 Apr; 258(4 Pt 1):C639-47. PubMed ID: 2159214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]